The subsequent transwell assays demonstrated that CPEB4 knockdown partly neutralized the suppressive effects of the miR-1246 inhibitor on NSCLC cell migration and invasion (Fig. 4c). The gene discussed is CPEB4; the disease is non-small cell lung carcinoma.